Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMT2: EPA for Colorectal Cancer Liver Metastases
NCT03428477Phase 3Active, not recruiting
- Sponsor
- Mark A Hull (Clinical Research Programs)
- Start
- May 2018
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3-acid triglycerides in colorectal cancer (CRC), sponsored by Mark A Hull (Clinical Research Programs). Started May 2018; status: active, not recruiting.
02
Drugs
omega-3-acid triglycerides
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03428477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03428477.